Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept

BACKGROUND: Two randomized phase III trials (EORTC55971 and CHORUS) showed similar progression-free and overall survival in primary or interval debulking surgery in ovarian cancer, however both studies had limitations with lower rate of complete resection and lack of surgical qualifications for part...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Gynecol Oncol
Главные авторы: Jiang, Rong, Zhu, Jianqing, Kim, Jae-Weon, Liu, Jihong, Kato, Kazuyoshi, Kim, Hee-Seung, Zhang, Yuqin, Zhang, Ping, Zhu, Tao, Aoki, Daisuke, Yu, Aijun, Chen, Xiaojun, Wang, Xipeng, Zhu, Ding, Zhang, Wei, Jia, Huixun, Shi, Tingyan, Gao, Wen, Yin, Sheng, Feng, Yanling, Xiang, Libing, Okamoto, Aikou, Zang, Rongyu
Формат: Artigo
Язык:Inglês
Опубликовано: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2020
Предметы:
Clinical Trial Protocol
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7440987/
https://ncbi.nlm.nih.gov/pubmed/32808504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2020.31.e86
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы